Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Moderna Therapeutics
A biotechnology startup company that develops messenger RNA based therapeutics to treat diseases.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
Also Known As
Moderna
AngelList URL
angel.co/moderna-therapeutics
B2X
B2B
Blog
modernatx.com/media-ce...dia/blogs
Board of Directors
Stéphane Bancel
Henri Termeer
Elizabeth Tallett
François Nader
Stephen Berenson
Sandra Horning
Robert Langer
Elizabeth Nabel
Noubar Afeyan
Paul Sagan
•••
Business Model
Commerce
CEO
Stephane Bancel
Stéphane Bancel
CFO
David Meline
CIK Number
1,682,852
Legal Name
Moderna, Inc.
Company Operating Status
Active
Competitors
Avidity Biosciences
Sputnik V
R-Zero
Exuma Biotechnology
OrphAI Therapeutics
0
Kernal Biologics
Meissa Vaccines
Arcturus Therapeutics
Pfizer
Country
United Kingdom
United States
Crunchbase URL
crunchbase.com/organiz...apeutics
CTO
Juan Andres
Date Incorporated
2016
Email Address
media@modernatx.com
ir@modernatx.com
Facebook URL
@modernatx
Fax Number
1-617-649-3910
Former CEO
Stephane Bancel
Founded Date
2010
Founder
Kenneth R. Chien
Robert S. Langer
Timothy A. Springer
Noubar Afeyan
Derrick Rossi
Full Address
200 Technology Sq Cambridge, MA, 02139-3578 United States
11Th Floor, Whitefriars, Lewins Mead, Bristol, England, BS1 2NT
Headquarters
Cambridge, Massachusetts
Incorporation Reference
11990046
Industry
Biology
Biotechnology
Healthcare
Infectious disease (medical specialty)
Internal medicine
Cardiology
Engineering
Endocrine disease
Biomedical engineering
Genomics
•••
Instagram URL
instagram.com/moderna_tx/
Investors
Abu Dhabi Investment Authority
The Pictet Group
Biomedical Advanced Research and Development Authority (BARDA)
BB Biotech
Alexion Pharmaceuticals
Viking Global Investors
Merck KgAa
AstraZeneca
Invus
Pictet Private Equity Investors S.A.
•••
Key People
Stéphane Bancel
Robert S. Langer
Stephen Hoge
Paul Sagan
Noubar Afeyan
David Meline
Latest Funding Round Date
July 26, 2020
Latest Funding Type
Series H round
Latest Postmoney Valuation
2,600,000,000
Legal Entity Identifier
549300EI6OKH5K5Q2G38
0
Legal classification
Private limited company
Delaware
0
LinkedIn URL
@company/modernatx
Location
United Kingdom
Cambridge, Massachusetts
Canada
United States
Bristol
Number of Employees
830
Number of Employees (Ranges)
1,001 – 5,000
Owner
Robert S. Langer
AstraZeneca
Noubar Afeyan
Parent Organization
Robert S. Langer
Noubar Afeyan
Patents Assigned (Count)
34
Phone Number
+16177146500
+12522277013
+18666633762
+12023076990
Pitchbook URL
pitchbook.com/profiles.../51074-47
Spinout
Onkaido Therapeutics
Exchange
Nasdaq
Stock Symbol
MRNA
Technologies Used
CRISPR
Ticker Symbol
MRNA
Total Funding Amount (USD)
2,707,000,000
Twitter URL
@moderna_tx
UKSIC Code
72110
Official Website
modernatx.com
modernatx.com/en-CA
Wellfound ID
moderna-therapeutics
Wikidata ID
Q17081612
Find more companies like Moderna Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE